Search the Newsreel

T. Rowe Price Associates (EHC) discloses 5.1% Encompass Health stake on Schedule 13G

T. Rowe Price Associates has filed a Schedule 13G, disclosing a 5.1% beneficial ownership stake in Encompass Health Corp (EHC), totaling 5,056,225 common stock shares. The filing indicates that T. Rowe Price Associates holds sole voting power over 4,897,333 shares and sole dispositive power …

Form 8K Encompass Health Corp For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Encompass Health Corp on August 13. The brief notice from Investing.com indicates this as a stock market event without providing further details on the content of the filing.

Encompass Health completes $100 million senior notes offering to repay debt

Encompass Health Corporation has successfully issued $100 million in 5.875% Senior Notes due 2034, generating net proceeds of approximately $96.9 million. These proceeds, along with existing cash, were used to repay a portion of its revolving credit facility. The company recently reported strong second-quarter …

Encompass Health issues $100M of 5.875% senior notes due 2034, nets ~$96.9M

Encompass Health (EHC) has completed a private issuance of $100 million in 5.875% Senior Notes due 2034, generating approximately $96.9 million after discounts and expenses. The proceeds, along with cash on hand, were utilized to reduce short-term borrowings by repaying a portion of the …

Encompass Health Corporation (EHC) Stock forecasts

This article provides stock forecast information for Encompass Health Corporation (EHC), noting that Argus has raised its target price for EHC to $138.00. The company's current price is $123.78, and it operates in the healthcare sector, providing post-acute healthcare services.

EHC6480675 Bond Price and Chart — FINRA:EHC6480675

This article provides details on the EHC6480675 bond, issued by Encompass Health Corporation. It includes key terms such as a 5.88% coupon and a maturity date of June 1, 2034, along with issuer information, sector, industry, and various identifiers. The bond currently shows no …

5 Revealing Analyst Questions From Encompass Health’s Q2 Earnings Call

Encompass Health Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Encompass Health EVP, general counsel John Darby sells $1.12 million in stock

John Patrick Darby, Executive Vice President, General Counsel, and Secretary of Encompass Health Corp (NYSE:EHC), sold 8,906 shares of the company’s common stock for approximately $1.12 million. The sale occurred on August 10, 2026, with shares trading near their 52-week high after a 14% …

Encompass Health president & CEO Mark Tarr sells $21.7m in stock

Mark J. Tarr, President and CEO of Encompass Health Corp (NYSE:EHC), sold 173,148 shares of the company’s common stock for approximately $21.7 million on August 10, 2026. Following these transactions, Mr. Tarr directly owns 267,814 shares. The sale occurred as EHC trades near its …

Insider Selling: Encompass Health (NYSE:EHC) CEO Sells 173,148 Shares

Encompass Health (EHC) EVP John Patrick Darby sells 8,906 shares in August trade

John Patrick Darby, EVP, General Counsel & Secretary of Encompass Health Corp (EHC), sold 8,906 shares of common stock on August 10, 2026. The shares were sold at a weighted average price of $125.95, totaling approximately $1.12 million. Following this transaction, Darby directly holds …

Encompass Health Prices $100M 5.875% Notes Due 2034 | EHC Stock News

Encompass Health (NYSE: EHC) announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034. These "Additional Notes" will reopen the existing 2034 series and carry the same terms, priced at 98.75% …

Encompass Health (EHC) insider plans sale of 18,869 vested RSA shares

An insider at Encompass Health Corporation, Douglas Coltharp, has filed a Form 144 to sell 18,869 shares of common stock, valued at approximately $2.36 million. The proposed sale is linked to restricted stock award vesting events from early 2025. Coltharp had previously sold 27,694 …

Encompass Health Corp SEC Filing (Aug 10, 2026)

This article reports on an SEC Form 144 filing by Encompass Health Corp (EHC) on August 10, 2026. The filing indicates a proposed sale of 173,148 shares of common stock with an aggregate market value of $21,722,174.82 by an individual who acquired the shares …

Encompass Health Prices $100 Million Add-On Senior Notes at 1.25% Discount to Par

Encompass Health Corp. (EHC) announced the pricing of an additional $100 million of its 5.875% Senior Notes due 2034, issued at a 1.25% discount to par. This tap offering will fund the repayment of borrowings under the company's revolving credit facility. The private placement …

Encompass Health prices private offering of additional 5.875% senior notes due 2034

BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034 (the "Additional Notes") at a price of 98.75% …

EHC Q2 Deep Dive: Higher-Acuity Growth, Expansion Plans, and Labor Initiatives Shape Outlook

EHC Q2 Deep Dive: Higher-Acuity Growth, Expansion Plans, and Labor Initiatives Shape Outlook Health care services provider Encompass Health (NYSE:EHC) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 9.6% year on year to $1.60 billion. The company expects the …

Encompass Health Intends to Use $100M Offering to Repay Debt

Encompass Health (NYSE: EHC) has launched a private offering of an additional $100 million in 5.875% senior notes due 2034. These notes will supplement an existing series and are intended to repay outstanding amounts under the company's senior secured revolving credit facility, effectively refinancing …

Encompass Health announces launch of private offering of 5.875% senior notes due 2034

BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5.875% senior notes maturing in 2034 (the "Additional Notes"), subject to market and other …

Encompass Health Corp. Announces Launch Of Private Offering Of $100 Million 5.875% Senior Notes Due 2034

Encompass Health Corp. has launched a private offering for an additional $100 million of 5.875% senior notes due in 2034. These new notes will be part of the same class as previously issued notes from May 2026 and will be guaranteed by the company's …

ENCOMPASS HEALTH CORP : TD COWEN RAISES TARGET PRICE TO $140 FROM $125

TD Cowen has increased its target price for Encompass Health Corp (EHC.N) to $140 from $125. This adjustment reflects an updated outlook from the analyst firm regarding the healthcare company's valuation. The information is sourced from Reuters.

Reinhart Partners LLC. Has $44.01 Million Stock Position in Encompass Health Corporation $EHC

Reinhart Partners LLC. increased its stake in Encompass Health Corporation (NYSE:EHC) by 1.9% in the second quarter, bringing its total holdings to 435,362 shares valued at approximately $44.01 million. Encompass Health reported strong quarterly results, exceeding analyst expectations with $1.55 EPS and $1.60 billion …

Encompass Health (EHC) Is Up 12.7% After Raising 2026 Guidance And Completing Major Buyback Program – Has The Bull Case Changed?

Is Encompass Health (EHC) Cheap After Its Earnings Beat And Higher 2026 Guidance?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Encompass Health (EHC) shares are in focus after the company reported second quarter revenue of about US$1.6b and earnings per share of US$1.55, both …

Encompass Health (EHC) Stock Trades Below Fair Value After a 110% Run

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Encompass Health stock has delivered a 110.2% total return over the past 5 years, and at a recent price of US$125.23 the valuation …

Encompass Health Q2 Earnings Call Highlights

Key Points Interested in Encompass Health Corporation? Here are five stocks we like better. Strong second-quarter performance prompted higher 2026 guidance: Revenue rose 9.6%, adjusted EBITDA increased 9.2% to $348 million, and adjusted EPS grew 10.7%, supported by higher discharges and patient acuity. Encompass …

Encompass Health Beats Q2 Earnings Estimates, Raises '26 View

Encompass Health (NYSE: EHC) grows Q2 2026 revenue and EPS

Encompass Health Corporation reported higher Q2 2026 results, with net operating revenues increasing to $1,597.4 million, driven by growth in patient discharges and net patient revenue per discharge. Net income attributable to Encompass Health was $153.9 million, and diluted EPS from continuing operations was …

ENCOMPASS HEALTH CORP : TRUIST SECURITIES RAISES TARGET PRICE TO $150 FROM $140

Truist Securities has increased its target price for Encompass Health Corp (EHC.N) from $140 to $150. This adjustment signals a more optimistic outlook from the financial firm regarding the company's future stock performance.

Encompass Health Raises 2026 Outlook, Expands Buyback Plan

Encompass Health (EHC) Shares Skyrocket, What You Need To Know

Encompass Health Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:EHC) 2026-08-06

Encompass Health Corporation reported strong Q2 2026 results, with revenue up 9.6%, adjusted EBITDA increasing 9.2%, and adjusted EPS rising 10.7%. The company raised its full-year 2026 guidance and highlighted outstanding patient outcomes, increased participation in clinical staff development programs, and continued investment in …